Education
About Us
Working with TipRanks
Follow Us
Abattis Bioceuticals (ATTBF)
:ATTBF
ATTBF Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume66.06K
Average Volume (3M)6.38K
Market Cap
$478.00
Enterprise Value$10.83M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta98.73
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding477,804,140
10 Day Avg. Volume2,812
30 Day Avg. Volume6,381
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.02
Price to Sales (P/S)0.00
P/FCF Ratio2.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ATTBF FAQ
What was Abattis Bioceuticals’s price range in the past 12 months?
Currently, no data Available
What is Abattis Bioceuticals’s market cap?
Abattis Bioceuticals’s market cap is $478.00.
When is Abattis Bioceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Abattis Bioceuticals’s earnings last quarter?
Currently, no data Available
Is Abattis Bioceuticals overvalued?
According to Wall Street analysts Abattis Bioceuticals’s price is currently Overvalued.
Does Abattis Bioceuticals pay dividends?
Abattis Bioceuticals does not currently pay dividends.
What is Abattis Bioceuticals’s EPS estimate?
Abattis Bioceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Abattis Bioceuticals have?
Abattis Bioceuticals has 477,804,140 shares outstanding.
What happened to Abattis Bioceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Abattis Bioceuticals?
Currently, no hedge funds are holding shares in ATTBF
Company Description
Abattis Bioceuticals
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
cbdMD
―
Cosmos Holdings
―
Flora Growth
―
Akanda Corp
―
Shuttle Pharmaceuticals Holdings, Inc.
―